Aptevo Therapeutics (APVO) Change in Inventory (2015 - 2019)
Aptevo Therapeutics (APVO) posted Change in Inventory of -$1.3 million for Q4 2019, down 360.78% sequentially from $515000.0 in Q3 2019.
Aptevo Therapeutics (APVO) Change in Inventory (2015 - 2019) Analysis & Trends
Aptevo Therapeutics has reported Change in Inventory for 5 years, with the latest figure at -$1.3 million in Q4 2019.
- Quarterly Change in Inventory changed N/A year-over-year to -$1.3 million in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $4.4 million (changed N/A YoY) and the FY2019 annual result came in at $4.4 million, up 475.17% from the prior year.
- Change in Inventory slipped to -$1.3 million in Q4 2019 per APVO's latest filing, from $515000.0 in the prior quarter.
- Over five years, Change in Inventory peaked at $2.9 million in Q3 2018 and troughed at -$8.6 million in Q3 2016.
- A 5-year average of -$226000.0 and a median of $257000.0 in 2018 frame the typical range for Change in Inventory.
- The sharpest annual moves came in 2016 and 2018: Change in Inventory sank 827.55% in 2016, then surged 1453.6% in 2018.
- Over 5 years, Change in Inventory stood at -$1.4 million in 2015, then tumbled by 253.51% to -$4.9 million in 2016, then jumped by 95.76% to -$209000.0 in 2017, then soared by 1507.18% to $2.9 million in 2018, then slumped by 145.66% to -$1.3 million in 2019.
- According to Business Quant data, Change in Inventory over the past three periods registered -$1.3 million, $515000.0, and $2.6 million for Q4 2019, Q3 2019, and Q2 2019 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 132.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 47.15 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -280,000.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 135.26 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 12.97 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Aptevo Therapeutics | 3.18 Mn | -6.61 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | -1.34 Mn |
| Dec 31, 2019 | -1.34 Mn |
| Sep 30, 2019 | 515,000.00 |
| Sep 30, 2019 | 515,000.00 |
| Jun 30, 2019 | 2.62 Mn |
| Jun 30, 2019 | 2.62 Mn |
| Mar 31, 2019 | 2.56 Mn |
| Mar 31, 2019 | 2.56 Mn |
| Sep 30, 2018 | 2.94 Mn |
| Sep 30, 2018 | 2.94 Mn |
| Jun 30, 2018 | 1.94 Mn |
| Jun 30, 2018 | 1.94 Mn |
| Mar 31, 2018 | 257,000.00 |
| Mar 31, 2018 | 257,000.00 |
| Dec 31, 2017 | -209,000.00 |
| Dec 31, 2017 | -209,000.00 |
| Sep 30, 2017 | -691,000.00 |
| Sep 30, 2017 | -691,000.00 |
| Jun 30, 2017 | 125,000.00 |
| Jun 30, 2017 | 125,000.00 |